Mike has focused on advising MedTech & Diagnostics companies since he joined Westwicke in early 2011, and has built strong relationships with both public and private clients.
Prior to joining Westwicke, Mike worked as an equity research analyst for over 13 years, including nine years on Wall Street. Most recently, he was responsible for primary research coverage of small-cap consumer stocks at T. Rowe Price, where he worked closely with small-cap mutual fund portfolio managers and was exposed to all facets of the buy-side investment process. Mike also spent a year in T. Rowe Price’s Global Investment Services group working on the institutional sales and client service team.
Mike holds a BA from James Madison University and received his Chartered Financial Analyst designation in 2006.